TechNavio recognizes the following companies as the key players in the Global Psoriasis Therapeutics market: Amgen Inc., Pfizer Inc., Janssen Biotech Inc., and Abbvie Inc.
Commenting on the report, an analyst from TechNavio’s team said: “One of the main trends witnessed in the Global Psoriasis Therapeutics market is the increased focus on combination therapies. A current trend witnessed in the Global Psoriasis Therapeutics market is the use of combination therapies for treating psoriasis. Light therapy along with topical treatment products are generally used in combination for the treatment of mild to moderate level of psoriasis. For severe psoriasis oral or injected drugs are used. Due to the severe side effects of these drugs, combination of therapies is used for the effective treatment of severe psoriasis. When the disease is more severe, topic therapy products such as cream is used in combination with oral medications or light therapy. For instance, Anthralin is sometimes used in combination with UV light. Light therapy is also used sometimes in combination with medications. Moreover, in Goeckerman therapy UVB treatment and coal tar treatment is used together as it is more effective than single therapy.”
According to the report, one of the main factors driving the market is the increasing uptake of biologics. In recent years the enhanced understanding of the molecular basis underlying psoriasis has led to the introduction of biological drugs, providing a new effective treatment option for this disease. Biologics aim key steps in the pathogenesis of psoriasis and can be categorized into three main categories: TNF alpha inhibitors, T cell inhibitors, and IL-12/IL-23 inhibitors.
Further, the report states that one of the main challenges is the adverse side effects. Although psoriasis drugs have numerous benefits, they can cause certain harmful side effects. Some of the common side effects caused by various psoriasis drugs are increased risk of skin cancers and lymphomas, hair loss, headache, nausea, and vomiting, suppression of immunity with possible serious infections such as pneumonia or herpes zoster.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are AstraZeneca plc, Bristol Myers Squibb Co., Celgene Corp., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline plc, Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., and Novartis International AG
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/report/global-psoriasis-therapeutics-market-201…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report -Global Psoriasis Therapeutics Market 2012-2016
